Asian Journal of Psychiatry
Volume 3, Issue 2 , Pages 60-63 , June 2010

Differences in the preferred antipsychotics for acute schizophrenia among young psychiatrists in two regions of Japan

  • Masaru Tateno

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Sapporo Medical University, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 0608543, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 11 611 2111; fax: +81 11 644 3041.
    • ,
  • Takahiro Kato

      Affiliations

    • Department of Neuropsychiatry, Graduate school of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
    • ,
  • Wakako Nakano

      Affiliations

    • Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan
    • ,
  • Shigenobu Kanba

      Affiliations

    • Department of Neuropsychiatry, Graduate school of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan
    • ,
  • Jun Nakamura

      Affiliations

    • Department of Psychiatry, School of Medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Yahatanishi-ku, Kitakyushu, Fukuoka 807-8555, Japan
    • ,
  • Toshikazu Saito

      Affiliations

    • Department of Neuropsychiatry, School of Medicine, Sapporo Medical University, South 1, West 16, Chuo-ku, Sapporo, Hokkaido 0608543, Japan

Received 19 May 2009 ,Revised 27 December 2009 ,Accepted 8 March 2010.

References 

  1. Allen MH, Currier GW, Carpenter D, Ross RW, Docherty JP. The expert consensus guideline series. Treatment of behavioral emergencies 2005. J. Psychiatr. Pract. 2005;11(Suppl 1):5–108quiz 110-102
  2. Asai K. From mental health law to mental health and welfare law. Psychiatry Clin. Neurosci. 1998;52:S247–S249Suppl
  3. Currier GW, Simpson GM. Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol and intramuscular lorazepam for treatment of psychotic agitation. J. Clin. Psychiatry. 2001;62(3):153–157
  4. Gaebel W, Weinmann S, Sartorius N, Rutz W, McIntyre JS. Schizophrenia practice guidelines: international survey and comparison. Br. J. Psychiatry. 2005;187:248–255
  5. Hatta K, Kawabata T, Yoshida K, Hamakawa H, Wakejima T, Furuta K, et al. Olanzapine orally disintegrating tablet vs. risperidone oral solution in the treatment of acutely agitated psychotic patients. Gen. Hosp. Psychiatry. 2008;30(4):367–371
  6. Ito H, Koyama A, Higuchi T. Polypharmacy and excessive dosing: psychiatrists’ perceptions of antipsychotic drug prescription. Br. J. Psychiatry. 2005;187:243–247
  7. Lehman AF, Lieberman JA, Dixon LB, McGlashan TH, Miller AL, Perkins DO, et al. Practice guideline for the treatment of patients with schizophrenia, second edition. Am J Psychiatry. 2004;161(Suppl. (2)):1–56
  8. Moore TA, Buchanan RW, Buckley PF, Chiles JA, Conley RR, Crismon ML, et al. The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. J. Clin. Psychiatry. 2007;68(11):1751–1762
  9. Onishi H, Yoshida I. Rapid change in Japanese medical education. Med. Teach. 2004;26(5):403–408
  10. Perkins MB, Jensen PS, Jaccard J, Gollwitzer P, Oettingen G, Pappadopulos E, et al. Applying theory-driven approaches to understanding and modifying clinicians’ behavior: what do we know?. Psychiatr. Serv. 2007;58(3):342–348
  11. Shiraishi, H., Igarashi, Y., Ikehara, T., Kimura, T., Takeshima, T., Yamamoto, T., Ohi, S., 2000. Law related to mental health and welfare of the person with mental disorder (full text as of date of enforcement in 2000), Translation, 2000.
  12. Sim K, Su A, Leong JY, Yip K, Chong MY, Fujii S, et al. High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study. Pharmacopsychiatry. 2004;37(4):175–179
  13. Tateno M, Uchida N, Kikuchi S, Kawada R, Kobayashi S, Nakano W, et al. The practice of child and adolescent psychiatry: a survey of early-career psychiatrists in Japan. Child Adolesc. Psychiatry Ment. Health. 2009;3(1):30
  14. Tateno M, Sugiura K, Uehara K, Fujisawa D, Zhao Y, Hashimoto N, et al. Attitude of young psychiatrists toward coercive measures in psychiatry: a case vignette study in Japan. Int. J. Ment. Health Syst. 2009;3(1):20
  15. Teo A. The current state of medical education in Japan: a system under reform. Med. Educ. 2007;41(3):302–308
  16. Tsuchiya KJ, Takei N. Focus on psychiatry in Japan. Br. J. Psychiatry. 2004;184:88–92
  17. Udomratn P. Prescribing habits of Thai psychiatrists in the treatment of a first episode schizophrenia. J. Psychiatr. Assoc. Thai. 1999;44(2):119–124
  18. Udomratn P, Srisurapanont M. Impact on Thai a psychiatrists of passive dissemination of a clinical practice guideline on prescribing attitudes in treatment-resistant schizophrenia. Neuropsychobiology. 2002;45:186–190
  19. Udomratn P, Ng CH. Outpatient prescribing practices in Asian countries, in ethno-psychopharmacology. In:  Ng CH,  Lin KM,  Singh BS,  Chiu E editor. Advances in Current Practice. Cambridge: Cambridge University Press; 2008;p. 135–143
  20. Weinmann S, Hoerger S, Erath M, Kilian R, Gaebel W, Becker T. Implementation of a schizophrenia practice guideline: clinical results. J. Clin. Psychiatry. 2008;69(8):1299–1306
  21. Yoshimura R, Okamoto T, Nakamura J, Tateno M, Otsuka K, Takahashi H, et al. Prescription pattern of antipsychotic drugs for schizophrenic inpatients in Japan: research on East Asia Psychotropic Prescription Pattern—antipsychotics study. Psychiatry Clin. Neurosci. 2006;60(6):778–779

PII: S1876-2018(10)00016-X

doi: 10.1016/j.ajp.2010.03.005

Asian Journal of Psychiatry
Volume 3, Issue 2 , Pages 60-63 , June 2010

Article Tools